International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study.
Journal
Drugs & aging
ISSN: 1179-1969
Titre abrégé: Drugs Aging
Pays: New Zealand
ID NLM: 9102074
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
accepted:
17
03
2021
pubmed:
14
4
2021
medline:
25
2
2023
entrez:
13
4
2021
Statut:
ppublish
Résumé
Explicit screening tools and implicit evaluation methods have been developed to assist healthcare professionals in the management of pharmacotherapy in older adults. As prescribing habits and locally available medications vary considerably between countries, guides tailored to the needs of specific regions may be required. We aimed to report the results of the international Delphi validation study for the Turkish Inappropriate Medication use in the Elderly (TIME) criteria set, which aims to detect inappropriate prescribing in older adults in Eastern Europe. The study was conducted between June 2019 and March 2020. Delphi rounds were conducted by the TIME international working group, which included 11 internationally recognized experts in geriatric pharmacotherapy as Delphi panelists. They were asked to indicate to what extent they agreed or disagreed with each TIME criterion, taking into account both the available evidence and their own experience. We used a five-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) and an online software program (SurveyMonkey After three Delphi rounds, 134 criteria were accepted and seven criteria were rejected, while 12 criteria did not achieve consensus, and so were not included in the final validated set of TIME criteria. We developed the internationally validated TIME criteria set based on a Delphi process involving international experts. The validation study suggests that the TIME criteria set can be applied in both central and Eastern European settings. Further studies are needed to assess the utility and benefit of the TIME criteria in reducing inappropriate drug use and improving clinical outcomes.
Identifiants
pubmed: 33847948
doi: 10.1007/s40266-021-00855-5
pii: 10.1007/s40266-021-00855-5
pmc: PMC8041618
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
513-521Références
Davies EA, O’Mahony MS. Adverse drug reactions in special populations—the elderly. Br J Clin Pharmacol. 2015;80:796–807.
doi: 10.1111/bcp.12596
Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6:212–33.
doi: 10.1177/2042098615613984
Mangin D, Bahat G, Golomb BA, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action. Drugs Aging. 2018;35:575–87.
doi: 10.1007/s40266-018-0554-2
Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70:1–11.
doi: 10.1007/s00228-013-1575-8
Chang CB, Lai HY, Hwang SJ, et al. The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people. Ther Adv Chronic Dis. 2019;10:2040622319879602.
doi: 10.1177/2040622319879602
Pazan F, Kather J, Wehling M. A systematic review and novel classification of listing tools to improve medication in older people. Eur J Clin Pharmacol. 2019;75:619–25.
doi: 10.1007/s00228-019-02634-z
Seppala LJ, Petrovic M, Ryg J, et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing. 2020. https://doi.org/10.1093/ageing/afaa249 .
doi: 10.1093/ageing/afaa249
pubmed: 33349863
Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2020. https://doi.org/10.1093/ageing/afaa159 .
doi: 10.1093/ageing/afaa159
pubmed: 32484853
Rodríguez-Pérez A, Alfaro-Lara ER, Albiñana-Perez S, et al. Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria. Geriatr Gerontol Int. 2017;17:2200–7.
doi: 10.1111/ggi.13062
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825–32.
doi: 10.1001/archinte.1991.00400090107019
Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.
doi: 10.5414/CPP46072
Bahat G, Ilhan B, Erdogan T, et al. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur Geriatr Med. 2020;11:491–8.
doi: 10.1007/s41999-020-00297-z
O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.
doi: 10.1093/ageing/afu145
Onder G, Landi F, Fusco D, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging. 2014;31:33–45.
doi: 10.1007/s40266-013-0134-4
Dalkey NC. The Delphi method: an experimental study of group opinion. RAND Corporation; 1969.
Tommelein E, Petrovic M, Somers A, et al. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S) tool. J Public Health (Oxf). 2016;38:e158-170.
doi: 10.1093/pubmed/fdv090
Pazan F, Weiss C, Wehling M. The EURO-FORTA (Fit fOR The Aged) list: international consensus validation of a clinical tool for improved drug treatment in older people. Drugs Aging. 2018;35:61–71.
doi: 10.1007/s40266-017-0514-2
American Geriatrics Society. Updated AGS Beers Criteria
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.
pubmed: 20827352
Olsson IN, Curman B, Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf. 2010;19:150–7.
doi: 10.1002/pds.1891
Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103–7.
pubmed: 10958706
Rancourt C, Moisan J, Baillargeon L, et al. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.
doi: 10.1186/1471-2318-4-9
Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25:777–93.
doi: 10.2165/00002512-200825090-00004
Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31.
doi: 10.1007/s00228-007-0324-2
Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.
doi: 10.1080/02813430902992215
Soiza RL, Subbarayan S, Antonio C, et al. The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy. Ther Adv Drug Saf. 2017;8:81–5.
doi: 10.1177/2042098616675851
Garfinkel D. Overview of current and future research and clinical directions for drug discontinuation: psychological, traditional and professional obstacles to deprescribing. Eur J Hosp Pharm. 2017;24:16–20.
doi: 10.1136/ejhpharm-2016-000959
Bilek AJ, Levy Y, Kab H, et al. Teaching physicians the GPGP method promotes deprescribing in both inpatient and outpatient settings. Ther Adv Drug Saf. 2019. https://doi.org/10.1177/2042098619895914 .
doi: 10.1177/2042098619895914
pubmed: 31908757
pmcid: 6935879
Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019. https://doi.org/10.1177/2042098619829431 .
doi: 10.1177/2042098619829431
pubmed: 30800270
pmcid: 6378636
Garfinkel D. Poly-de-prescribing vs polypharmacy—the weapon to fight an iatrogenic epidemic: an overview. Eur J Geriatr Gerontol. 2019;1:1–10.
doi: 10.4274/ejgg.galenos.2019.14
Mangin D, Garfinkel D. Foreword to the first special collection: addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use. Ther Adv Drug Saf. 2019. https://doi.org/10.1177/2042098619883156 .
doi: 10.1177/2042098619883156
pubmed: 31673327
pmcid: 6804352